Concepedia

Meng-Wei Ko

MK

10

Publications

365

Citations

10

H-Index

2018

Active since

Affiliations

University of California, Los Angeles(Current)

UCLA Jonsson Comprehensive Cancer Center

Medical College of Wisconsin

Maharaj Institute of Immune Regenerative Medicine

University of Ljubljana

Meng-Wei Ko is an author at University of California, Los Angeles specializing in medicine, immunology, and t cell immunity.

ORCID

Top concepts

Publications per year

2018–2023

10

Publications

10

Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors<i>in vivo</i>in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs

Kawaljit Kaur, Paytsar Topchyan, Anna Kozłowska et al. · OncoImmunology · 2018 · 70 citations · Full text

Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice

Kawaljit Kaur, Anna Kozłowska, Paytsar Topchyan et al. · Cancers · 2019 · 66 citations · Full text

Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres

Barbara Breznik, Meng-Wei Ko, Christopher Tse et al. · Communications Biology · 2022 · 47 citations · Full text

Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells

Kawaljit Kaur, Meng-Wei Ko, Nick Ohanian et al. · Scientific Reports · 2020 · 40 citations · Full text

ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor

Kawaljit Kaur, Tahmineh Safaie, Meng-Wei Ko et al. · Cancers · 2021 · 40 citations · Full text

Rows per page

1–5 of 10